Its approval was supported by the Phase III ARCADIA clinical trial program, which included more than 1,700 patients and found that Nemluvio given every four weeks led to significant improvements in skin clearance versus placebo
doi: 10.1172/JCI200113155 9 BalandraudN.RoudierJ
While patients may wonder about potential urinary tract infection (UTI) risks, current clinical evidence does not establish a causal link between semaglutide and UTIs
A1C reflects a longer-term glucose trend, while electrolytes and kidney markers may need earlier evaluation during persistent vomiting, diarrhea, or dehydration
Regarding environmental factors, high iodine intake, selenium deficiency, pollutants such as tobacco smoke, infectious diseases such as chronic hepatitis C, and certain drugs are implicated in the development of autoimmune thyroiditis (16.1: Duntas LH
In addition, semaglutide is not suitable for breastfeeding and pregnant females